《Cancer Biology & Medicine》雜志的最新年發(fā)文量為69篇。
這表明該刊在每年都會(huì)精選并發(fā)表一定數(shù)量的高質(zhì)量文章，以保持其在醫(yī)學(xué)：研究與實(shí)驗(yàn)領(lǐng)域的學(xué)術(shù)影響力。
該刊聚焦于醫(yī)學(xué)-醫(yī)學(xué)：研究與實(shí)驗(yàn)領(lǐng)域的前沿研究，致力于推動(dòng)該領(lǐng)域新技術(shù)和新知識(shí)的傳播與應(yīng)用。同時(shí)它積極鼓勵(lì)研究人員詳細(xì)發(fā)表其高質(zhì)量的實(shí)驗(yàn)研究和理論成果。
該刊的平均審稿周期約為 12 Weeks 。
Cancer Biology & Medicine 雜志發(fā)文統(tǒng)計(jì)
文章名稱引用次數(shù)
- LncRNA PVT1 promotes ovarian cancer progression by silencing miR-21421
- PD-1/PD-L1 pathway blockade works as an effective and practical therapy for cancer immunotherapy18
- Dual-specificity phosphatase 6 (DUSP6): a review of its molecular characteristics and clinical relevance in cancer16
- Circular RNAs and human glioma16
- Enterolactone modulates the ERK/NF-kappa B/Snail signaling pathway in triple-negative breast cancer cell line MDA-MB-231 to revert the TGF-beta-induced epithelial-mesenchymal transition13
- Advances in isolation and detection of circulating tumor cells based on microfluidics12
- Reactive capillary hemangiomas: a novel dermatologic toxicity following anti-PD-1 treatment with SHR-121011
- A four-gene signature-derived risk score for glioblastoma: prospects for prognostic and response predictive analyses10
- Aberrant expression of enzymes regulating m(6)A mRNA methylation: implication in cancer10
- Key questions about the checkpoint blockade-are microRNAs an answer?10
國(guó)家/地區(qū)發(fā)文量
- CHINA MAINLAND157
- USA28
- Japan4
- Brazil3
- Canada3
- GERMANY (FED REP GER)3
- Malaysia3
- Australia2
- Iran2
- Italy2
